Artemis Program

GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial

system
By system
July 14, 2026 • 49 views
Original source: Biztoc.com
GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial

GSK's bet on Hansoh Pharmaceutical's antibody-drug conjugate (ADC) seems to be paying off as the drug met all its endpoints in a Phase III trial in China. In the pivotal ARTEMIS-008 trial (NCT06498479), risvutatug rezetecan (Ris-Rez) met its primary endpoint …

system
system

Article Author

Related Articles
Defense spending lifts Europe’s space economy
2 hours ago
Craig-Hallum Maintains a Buy on Intuitive Machines (LUNR) Despite 40% Decline Over the Past Month
2 hours ago
The most common type of planet discovered in the Milky Way may be a world that does not exist in our solar system — larger than Earth, smaller than Neptune, and wrapped in an atmosphere we barely understand
2 hours ago
The Government Wants to Turn Abandoned Oil Rigs Into Rocket Launch Pads
2 hours ago
Topic Tags
Nasa Artemis Ii Lunar Mission Space Launch System Artemis Iii Orion Spacecraft Blue Origin Spacex Artemis Program Reid Wiseman Deep Space New Glenn Commercial Launch Low Earth Orbit Orion Tiangong Chinese National Space Administration Crewed Spaceflight Pbs Documentary Moon Exploration Ng 3 Rocket Reusability Be 4 Cape Canaveral Vulcan Centaur United Launch Alliance Space Force Solid Rocket Boosters National Security Space Launch Gem 63xlmotor
Stay Updated

Subscribe to our newsletter for the latest news